Quick Takeaways
- FMR LLC filed SCHEDULE 13G for INOVIO PHARMACEUTICALS INC COMMON STOCK (INO).
- Disclosed ownership: 15%.
- Date of event: 28 Nov 2025.
FMR LLC - 28 Nov 2025 SCHEDULE 13G Report for INOVIO PHARMACEUTICALS INC COMMON STOCK (INO)
- Filing Manager
- FMR LLC
- Reporting Manager
- FMR LLC
- Symbol
- INO
- Shares outstanding
- 66,531,514 shares
- Disclosed Ownership
- 9,846,664 shares
- Ownership
- 15%
- Form type
- SCHEDULE 13G
- Filing time
- 05 Dec 2025, 14:03:43 UTC
- Date of event
- 28 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"FMR LLC disclosed 15% ownership in INOVIO PHARMACEUTICALS INC COMMON STOCK (INO) on 28 Nov 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 05 Dec 2025, 14:03.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| FMR LLC | 15% | 9,846,664 | 9,846,664 | 0 | Stephanie J. Brown | Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* | |
| Abigail P. Johnson | 15% | 9,846,664 | 0 | 0 | Stephanie J. Brown | Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson** |